Vorinostat Does Not Improve Outcome in Patients with Acute Myeloid Leukemia and High Risk Myelodysplasia Treated with Azacitidine: Results of the UK Trials Acceleration Programme Ravva Trial
Craddock C., Houlton AE., Ferguson P., Raghavan M., Fox S., Dudley L., Quek LS., Cavenagh JD., Dennis M., McMullin MF., Pillai SP., Kelly R., Siddique S., Wheatley K., Vyas P.